Life Sciences Tools and Services
Company Overview of Seahorse Bioscience, Inc.
Seahorse Bioscience, Inc. engages in the design, development, manufacture, and supply of analytical instruments, biomanufacturing systems, and consumable labware products for biological research and drug discovery to the life sciences industry. It offers a line of extracellular flux (XF) instruments, including XFe96 and XFe24 analyzers that measure mitochondrial respiration and glycolysis in cells; XF24-3 analyzer that enables the measurement of the TCA cycle, as well as mitochondrial respiration and glycolysis; and XF prep station that removes growth medium replacing with run medium. The company’s consumable products include XF fluxpaks, cell culture and islet capture microplates, stress te...
16 Esquire Road
North Billerica, MA 01862
Founded in 2000
Key Executives for Seahorse Bioscience, Inc.
Founder and Vice President of Seahorse Labware
Founder and Vice President of Administration & Finance
Founder and Chief Technology Officer
Founder and Vice President of Sales & Marketing
Compensation as of Fiscal Year 2014.
Seahorse Bioscience, Inc. Key Developments
Seahorse Bioscience, Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-03-2013 08:00 AM
May 21 13
Seahorse Bioscience, Inc. Presents at Jefferies 2013 Global Healthcare Conference, Jun-03-2013 08:00 AM. Venue: Grand Hyatt Hotel, 109 East 42nd Street at Grand Central, New York, New York, United States. Speakers: Jay Teich, Founder, Chairman, Chief Executive Officer and President.
Seahorse Bioscience Launches the XF Plasma Membrane Permeabilizer
Apr 1 13
Seahorse Bioscience recently launched the XF Plasma Membrane Permeabilizer (PMP), a reagent that enables scientists to measure the biochemistry and mechanisms of mitochondrial dysfunction, without the need for mitochondrial isolation or detergent-based permeabilization methods. XF PMP was developed in partnership with the Pioneer Valley Life Sciences Institute (PVLSI), a joint venture of Baystate Medical Center and the University of Massachusetts Amherst, with the dual missions of biomedical research and economic development. The technology was exclusively licensed to Seahorse Bioscience by UMass Amherst and Baystate Health, the parent organization of Baystate Medical Center. XF PMP can be used with the Seahorse XF(e) Extracellular Flux Analyzer, an instrument for measuring cell metabolism, in real-time, in a microplate. XF PMP creates pores in the cell plasma membrane, and delivers a degree of precision and ease-of-use that has not been available to scientists researching cell metabolism. A key element of XF PMP is the ability to assess mitochondrial function in adherent monolayers of permeabilized cells without damaging the mitochondrial membrane. By doing so, XF PMP enables metabolic substrates, compounds, and small proteins that otherwise would not cross the plasma membrane to reach the mitochondria.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|